Gadolinium News and Research

RSS

Cardiac MRI shows a similar injury pattern for vaccine-associated myocarditis

Vaccine-associated myocarditis shows a similar injury pattern on cardiac MRI compared to other causes of myocarditis, but abnormalities are less severe, according to a new study published in the journal Radiology.

15 Feb 2022

Researchers develop new technique to open the blood-brain barrier in lab animals

University of Maryland School of Medicine researchers developed a technique in laboratory animals to consistently and reproducibly open the blood-brain barrier.

31 Jan 2022

Vaccine hypersensitivity in children

A new paper published in Pediatric Allergy and Immunity provides a useful overview of such reactions in relation to pediatric vaccines.

31 Jan 2022

Sensor based on quantum effects may offer faster and accurate detection of SARS-CoV-2 virus

A novel approach to testing for the presence of the virus that causes Covid-19 may lead to tests that are faster, less expensive, and potentially less prone to erroneous results than existing detection methods. Though the work, based on quantum effects, is still theoretical, these detectors could potentially be adapted to detect virtually any virus, the researchers say.

21 Dec 2021

Role of cardiac MRI for assessing myocarditis after COVID-19 vaccination in adolescents

According to ARRS' American Journal of Roentgenology (AJR), radiologists need to be cognizant of the association between coronavirus disease (COVID-19) mRNA vaccination and myocarditis, as well as the role of cardiac MRI for assessing suspected myocarditis postvaccination.

30 Oct 2021

Researchers develop efficient approach to identify 3D features of post-infarction scarring

A multidisciplinary team of scientists based at the Universidad de Valladolid and the Centro Nacional de Investigaciones Cardiovasculares (CNIC) has developed a highly efficient method for identifying the 3-dimensional features of the scar tissue formed after a myocardial infarction.

28 Sep 2021

Engineers optimize nuclear magnetic resonance tools through molecular dynamics simulations

Gadolinium-based contrast agents, the gold standard in magnetic resonance imaging(MRI) to determine the health of a patient, can be improved, according to Rice University engineers who are refining models they first used to enhance oil and gas recovery.

21 Sep 2021

Gd-doped iron oxide nanoclusters offer a way to diagnose early orthotopic cancer

To realize precise diagnosis of early-stage cancer for effective treatment and better prognosis, high-resolution magnetic resonance imaging (MRI) is indispensable with the help of contrast agents.

15 Sep 2021

Results from Phase 0/1 trial of ribociclib plus everolimus in patients with high-grade glioma announced

The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, announced results from their Phase 0/1 clinical trial of ribociclib plus everolimus in patients with high-grade glioma (HGG).

13 Sep 2021

Researchers create a QIBA profile for cartilage compositional imaging

New recommendations will help provide more reliable, reproducible results for MRI-based measurements of cartilage degeneration in the knee, helping to slow down disease and prevent progression to irreversible osteoarthritis, according to a special report published in the journal Radiology.

7 Sep 2021

Quantum physics helps trigger cancer cell death

Cancer cell death is triggered within three days when X-rays are shone onto tumor tissue containing iodine-carrying nanoparticles.

14 Jul 2021

Researchers map potential toxicity of lanthanide metals used in medicine

Lanthanides are rare-earth heavy metals with useful magnetic properties and a knack for emitting light. Researchers had long assumed that lanthanides' toxicity risk was low and therefore safe to implement in a number of high-tech breakthroughs we now take for granted: from OLEDs (organic light-emitting displays)¬¬ to medical MRIs and even hybrid vehicles.

9 Jun 2021

FDA approves clinical trials to test the safety of cancer-detection technology

The U.S. Food and Drug Administration has approved human clinical trials to test the safety of cancer-detection technology developed at Case Western Reserve University: a tumor-targeting contrast agent that accurately detects aggressive prostate cancer in a magnetic resonance imaging (MRI) scan.

22 Apr 2021

New high-performance, safe MRI contrast agent for 3D vascular mapping

Heart attack and stroke are the first and second leading causes of death in developed countries, respectively. As the disease often results in sudden death with few special prognostic symptoms, early diagnosis is very important.

10 Mar 2021

Novel MRI contrast agent shows strong potential as safer alternative to current products

Adding a contrast-enhancing agent to magnetic resonance imaging (MRI) significantly improves image quality and allows radiologists who interpret MRI scans to pick up subtle anatomic details and abnormalities that might otherwise be missed.

15 Dec 2020

Novel MRI contrast agent offers hope for early detection of Alzheimer’s disease

Hong Kong Baptist University scientists have invented a novel contrast agent for magnetic resonance imaging, which enables real-time visualization and detection of the size and number of amyloid-beta in the brain, a main hallmark of Alzheimer’s disease.

2 Nov 2020

Gadolinium News and Research

Cardiac MRI shows a similar injury pattern for vaccine-associated myocarditis

Researchers develop new technique to open the blood-brain barrier in lab animals

Vaccine hypersensitivity in children

Sensor based on quantum effects may offer faster and accurate detection of SARS-CoV-2 virus

Role of cardiac MRI for assessing myocarditis after COVID-19 vaccination in adolescents

Researchers develop efficient approach to identify 3D features of post-infarction scarring

Engineers optimize nuclear magnetic resonance tools through molecular dynamics simulations

Gd-doped iron oxide nanoclusters offer a way to diagnose early orthotopic cancer

Results from Phase 0/1 trial of ribociclib plus everolimus in patients with high-grade glioma announced

Researchers create a QIBA profile for cartilage compositional imaging

Quantum physics helps trigger cancer cell death

Researchers map potential toxicity of lanthanide metals used in medicine

FDA approves clinical trials to test the safety of cancer-detection technology

New high-performance, safe MRI contrast agent for 3D vascular mapping

Novel MRI contrast agent shows strong potential as safer alternative to current products

Novel MRI contrast agent offers hope for early detection of Alzheimer’s disease

Study finds low risk of adverse events from cardiac MRI contrast agents

Research shows Imagion nanoparticles enable low-field MRI

Examining cardiovascular injuries in patients who recovered from COVID-9 infection

$3 million grant helps Dartmouth engineers to develop multi-modal breast imaging platform

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News